Cargando…
Clozapine Therapy and COVID-19: A Systematic Review of the Prevalence Rates, Health Outcomes, Hematological Markers, and Patient Perspectives
BACKGROUND/OBJECTIVES: There have been concerns that clozapine treatment may undermine the capacity of the body to fight infection and increase the vulnerability to contracting COVID-19. This review of recent cohort studies investigated (1) whether people with a severe psychiatric disorder are at in...
Autores principales: | Giles, Grace, Varghese, Sunny, Shymko, Gordon, Nguyen, Thinh, Waters, Flavie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620749/ https://www.ncbi.nlm.nih.gov/pubmed/36242537 http://dx.doi.org/10.1093/schbul/sbac148 |
Ejemplares similares
-
Cluster Analysis of Clozapine Consumer Perspectives and Comparison to Consumers on Other Antipsychotics
por: Sharma, Sumeet, et al.
Publicado: (2021) -
Clozapine Response in Schizophrenia and Hematological Changes
por: Blackman, Graham, et al.
Publicado: (2021) -
Time of onset of hematological side effects with Clozapine
por: Ktari, H., et al.
Publicado: (2022) -
Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia
por: McQueen, Grant, et al.
Publicado: (2021) -
Clozapine: Current perspective
por: Solanki, Ram K., et al.
Publicado: (2007)